Effects of S-adenosylmethionine augmentation of serotonin-reuptake inhibitor antidepressants on cognitive symptoms of major depressive disorder.
J Affect Disord., Feb;136(3):1174-8 (2012)
Efficacy of dose increase among nonresponders to low-dose aripiprazole augmentation in patients with inadequate response to antidepressant treatment: a randomized, double-blind, placebo-controlled, efficacy trial.
J Clin Psychiatry., Mar;73(3):353-7 (2012)
A double-blind, placebo-controlled trial of the NMDA glycine site antagonist, GW468816, for prevention of relapse to smoking in females.
J Clin Psychopharmacol., Oct;31(5):597-602 (2011)
A double-blind, placebo-controlled study of aripiprazole adjunctive to antidepressant therapy among depressed outpatients with inadequate response to prior antidepressant therapy (ADAPT-A Study).
Psychother Psychosom., 81(2):87-97 (2012)
Major depressive disorder with psychosis-like symptoms among Latinos.
Psychiatr Serv., 63(5):482-7 (2012)
Bioavailability of S-adenosyl methionine and impact on response in a randomized, double-blind, placebo-controlled trial in major depressive disorder.
J Clin Psychiatry., Jun;73(6):843-8 (2012)
Depression and eating disorders: treatment and course.
J Affect Disord., May;130(3):470-7 (2011)
A post hoc analysis of the effect of nightly administration of eszopiclone and a selective serotonin reuptake inhibitor in patients with insomnia and anxious depression.
J Clin Psychiatry., Apr;72(4):473-9 (2011)
Second-tier natural antidepressants: review and critique.
J Affect Disord., May;130(3):343-57 (2011)
Complementary and alternative medicine for major depressive disorder: a meta-analysis of patient characteristics, placebo-response rates, and treatment outcomes relative to standard antidepressants.
J Clin Psychiatry., Jun;71(6):682-8 (2010)
Folate in depression: efficacy, safety, differences in formulations, and clinical issues.
J Clin Psychiatry., 70 Suppl 5:12-7 (2009)
Update and critique of natural remedies as antidepressant treatments.
Obstet. Gynecol. Clin. North Am., Dec;36(4):789-807, x (2009)
Deficits in psychological well-being and quality-of-life in minor depression: implications for DSM-V.
CNS Neurosci Ther., Aug;16(4):208-16 (2010)
Anxious depression and early changes in the HAMD-17 anxiety-somatization factor items and antidepressant treatment outcome.
Int Clin Psychopharmacol., Jul;25(4):214-7 (2010)
Complementary and alternative medicine in major depressive disorder: the American Psychiatric Association Task Force report.
J Clin Psychiatry., Jun;71(6):669-81 (2010)
S-adenosyl methionine (SAMe) augmentation of serotonin reuptake inhibitors for antidepressant nonresponders with major depressive disorder: a double-blind, randomized clinical trial.
Am J Psychiatry., Aug;167(8):942-8 (2010)
Anger attacks in major depressive disorder and serum levels of homocysteine.
Biol. Psychiatry., Aug;60(3):270-4 (2006)
Outcomes of recognizing depressed Chinese American patients in primary care.
Int J Psychiatry Med., 35(3):213-24 (2005)
The combination of duloxetine and bupropion for treatment-resistant major depressive disorder.
Depress Anxiety., 23(3):178-81 (2006)
Dysfunctional attitudes and personality disorder comorbidity during long-term treatment of MDD.
Depress Anxiety., 24(6):433-9 (2007)